Cogent Biosciences, Inc.
COGT · NASDAQ
Bulios Fair Price
$17.94
43.9% downside
Trenutna cena
$32
Po podatkih Bulios Fair Price je delnica COGT trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Cogent Biosciences, Inc. (COGT) is an American biotechnology company focused on the development of innovative therapeutics for patients with oncological and genetic diseases. With a primary emphasis on targeted therapy and gene therapy, Cogent Biosciences aims to provide effective and personalized treatments. Their research and development efforts are centered on identifying new therapeutic targets and discovering innovative approaches to treatment. The shares of Cogent Biosciences, Inc. (COGT) may be suitable for investors seeking opportunities in the field of biotechnology and innovative therapeutics with potential in oncology and genetic diseases.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Andrew R. Robbins
Employees
258
Headquarters
Waltham
Prihajajoči dogodki
Earnings
Upcoming earnings report